Clomiphene-Induced Severe Hypertriglyceridemia and Pancreatitis

1990 Clark, 1981, The agonistic-antagonistic properties of clomiphene: a review, Pharmacol Ther, 15, 467, 10.1016/0163-7258(81)90055-3 Baker, 1996, Clinical uses of antiestrogens, Obstes Gynecol Surv, 51, 45, 10.1097/00006254-199601000-00021 Schally, 1970, Alteration of LH and FSH release in rats treated with clomiphene on its isomers, Am J Obstet Gynecol, 107, 1156, 10.1016/S0002-9378(15)30364-1 Nagel, 1970, Contrasting actions of cis- and trans-clomiphene on the release of FSH and FSH-RF in the female rat, Harm Metab Res, 2, 344, 10.1055/s-0028-1095051 Love, 1991, Effects of tamoxifen on cardiovascular risk factors in postmenopausal women, Ann Intern Med, 115, 860, 10.7326/0003-4819-115-11-860 O'Brien, 1997, Lipids and lipoproteins in women, Mayo Clin Proc, 72, 235, 10.4065/72.3.235 Grey, 1995, The effects of the anti-estrogen tamoxifen on cardiovascular risk factors in normal post-menopausal women, J Clin Endocrinol Metab, 60, 3191, 10.1210/jc.80.11.3191 Hozumi, 1997, Severe hypertriglyceridemia caused by lamoxifen-treatment after breast cancer surgery, Endocr J, 44, 745, 10.1507/endocrj.44.745 Brun, 1986, Severe lipemia induced by tamoxifen, Cancer, 57, 2123, 10.1002/1097-0142(19860601)57:11<2123::AID-CNCR2820571106>3.0.CO;2-2 Hozumi, 1998, Effect of tamoxifen on serum lipid metabolism, J Clin Endocrinol Metab, 83, 1633, 10.1210/jc.83.5.1633 Frolik, 1996, Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCI, tamoxifen, estrogen, and alendronate, Bone, 18, 621, 10.1016/8756-3282(96)00085-3 Walsh, 1998, Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women, JAMA, 279, 1445, 10.1001/jama.279.18.1445 Draper, 1996, A controlled trial of raloxifene (LY139481) HCI: impact on bone turnover and serum lipid profile in healthy postmenopausal women, J Bone Miner Res, 11, 835, 10.1002/jbmr.5650110615 Ordovas, 1984, Plasma lipids and cholesterol esterificalion rate during pregnancy, Obstet Gynecol, 63, 20 Potter, 1979, The hyperlipidemia of pregnancy in normal and compl icated pregnancies, Am J Obstet Gynecol, 133, 165, 10.1016/0002-9378(79)90469-1 Chiang, 1995, Alterations of serum lipid levels and their biological relevances during and after pregnancy, Life Sci, 56, 2367, 10.1016/0024-3205(95)00230-4 Keilson, 1996, Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene, Ann Intern Med, 124, 425, 10.7326/0003-4819-124-4-199602150-00007 Saravanan, 1996, Plasma exchange for dramatic gestational hyperlipidemie pancreatitis, J Clin Gasiroenterol, 22, 295, 10.1097/00004836-199606000-00011 Watts, 1992, Management of patients with severe hypertriglyceridaemia during pregnancy: report of two cases with familial lipoprotein lipase deficiency, Br J Obstet Gynaecol, 99, 163, 10.1111/j.1471-0528.1992.tb14481.x Nies, 1990, Hyperlipidemic pancreatitis in pregnancy: a case report and review of the literature, Am J Perinatal, 7, 166, 10.1055/s-2007-999472 Glueck, 1980, Pancreatitis, familial hypertriglyceridemia, and pregnancy, Am J Obstes Gynecol, 136, 755, 10.1016/0002-9378(80)90452-4 Economides, 1990, Hypertriglyceridemia and hypoxemia in small-for-gestational-age fetuses (published correction appears in Am J ObsSet Gynecol. 1990;162:1363], Am J Obsset Gynecol, 162, 382, 10.1016/0002-9378(90)90391-J Swoboda, 1993, Extracorporeal lipid elimination for treatment of gestational hyperlipidemic pancreatitis, Gastroenterology, 104, 1527, 10.1016/0016-5085(93)90366-K